Mbangiwa Tshepiso, Kasvosve Ishmael, Anderson Motswedi, Thami Prisca K, Choga Wonderful T, Needleman Austen, Phinius Bonolo B, Moyo Sikhulile, Leteane Melvin, Leidner Jean, Blackard Jason T, Mayondi Gloria, Kammerer Betsy, Musonda Rosemary M, Essex Max, Lockman Shahin, Gaseitsiwe Simani
Botswana Harvard AIDS Institute Partnership, Gaborone BO320, Botswana.
Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Botswana, Gaborone 0022, Botswana.
Genes (Basel). 2018 May 17;9(5):259. doi: 10.3390/genes9050259.
The hepatitis B virus (HBV) is a global problem; however, the burden of HBV infection in pregnant women in Botswana is unknown. We sought to determine the prevalence of chronic and occult HBV infection in human immunodeficiency virus (HIV)-infected and -uninfected pregnant women in Botswana. Samples from 752 pregnant women were tested for hepatitis B surface antigen (HBsAg), and HBsAg-positive samples were tested for hepatitis B e antigen (HBeAg) and HBV DNA load. Samples that were HBsAg negative were screened for occult HBV infection by determining the HBV DNA load. HBV genotypes were determined based on a 415-base-pair fragment of the surface gene. Among the 752 women tested during pregnancy or early postpartum, 16 (2.1%) (95% confidence interval (CI): 2.0⁻2.2) were HBsAg-positive. The prevalence of chronic HBV infection was higher (3.1%) among HIV-infected (95% CI: 3.0⁻3.2) compared with HIV-uninfected women (1.1%) (95% CI: 1.07⁻1.1, = 0.057). Among the 622 HBsAg-negative women, the prevalence of occult HBV infection was 6.6% (95% CI: 6.5⁻6.7). Three of thirteen HBsAg-positive participants were HBeAg-positive, and all were HIV-negative. Of the 11 maternal samples successfully genotyped, five (45.5%) were genotype D3, five (45.5%) were genotype A1, and one was genotype E (9%). Low and similar proportions of HIV-infected and -uninfected pregnant women in Botswana had occult or chronic HBV infection. We identified a subset of HIV-negative pregnant women who had high HBV DNA levels and were HBeAg-positive, and thus likely to transmit HBV to their infants.
乙型肝炎病毒(HBV)是一个全球性问题;然而,博茨瓦纳孕妇感染HBV的负担尚不清楚。我们试图确定博茨瓦纳感染和未感染人类免疫缺陷病毒(HIV)的孕妇中慢性和隐匿性HBV感染的患病率。对752名孕妇的样本进行了乙型肝炎表面抗原(HBsAg)检测,对HBsAg阳性样本进行了乙型肝炎e抗原(HBeAg)和HBV DNA载量检测。对HBsAg阴性的样本通过测定HBV DNA载量来筛查隐匿性HBV感染。根据表面基因的415个碱基对片段确定HBV基因型。在孕期或产后早期接受检测的752名女性中,16名(2.1%)(95%置信区间(CI):2.0⁻2.2)HBsAg呈阳性。与未感染HIV的女性(1.1%)(95%CI:1.07⁻1.1,P = 0.057)相比,感染HIV的女性中慢性HBV感染的患病率更高(3.1%)(95%CI:3.0⁻3.2)。在622名HBsAg阴性的女性中,隐匿性HBV感染的患病率为6.6%(95%CI:6.5⁻6.7)。13名HBsAg阳性参与者中有3名HBeAg呈阳性,且均未感染HIV。在成功进行基因分型 的11份母亲样本中,5份(45.5%)为D3基因型,5份(45.5%)为A1基因型,1份为E基因型(9%)。博茨瓦纳感染和未感染HIV的孕妇中隐匿性或慢性HBV感染的比例较低且相似。我们确定了一部分未感染HIV的孕妇,她们的HBV DNA水平较高且HBeAg呈阳性,因此很可能将HBV传播给她们的婴儿。